Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field NEURAMINIDASE INHIBITORS
Anti-infectives · Anti-infectives · Level 3
AMPHOTERICIN B
Anti-infectives · Anti-infectives · Level 3
Mechanism of action

inhibit neurominidase resulting in impaired viral release from infected cells. Neurominidase cleaves the sialic acid on the cell membrane allowing viral budding.

Polyenes specifically target fungal membranes. They bind ergosterol, which is the principal sterol in fungal membranes as opposed to cholesterol found in host membranes. This interference creates a transmembrane channel and the resultant change in permeability allows leakage of intracellular components

Absorption —

only administered IV

Distribution —

Poor tissue penetration. Negligable CSF or urine penetration.

Protein binding —

Highly protein bound

Metabolism —

Metabolised by the liver

Excretion —

poorly characterized but does not accumulate in renal failure

Adverse Effects Toxicity

1. Psychiatric symptoms
2. N/V/D
3. Bronchospasm

Dose related nephrotoxicity
Infusion related reactions (hypotension, fever, rigors)

Antimicrobial Spectrum —

Broad antifungal cover including candida, Cryptococcus, aspergillus and zygomyces

Class Group

Antiviral

Antifungal

Introduction

Oseltamivir and Zanamivir

Polyene

Legacy Cicm Level

Level 3

Level 3